Castle Biosciences (CSTL) EBT Margin Growth (1y) (2019 - 2026)
Castle Biosciences (CSTL) EBT Margin Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 30.00 |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 617.00 |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 163.00 |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 665.00 |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -115.00 |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 113.00 |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -646.00 |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 288.00 |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | -37.00 |
| 10 | Castle Biosciences | 926.56 Mn | 659.75 Mn | 79.85 Mn | -147.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -147.00 |
| Mar 31, 2026 | 1,263.00 |
| Dec 31, 2025 | -1,225.00 |
| Sep 30, 2025 | -1,012.00 |
| Jun 30, 2025 | -923.00 |
| Mar 31, 2025 | -2,645.00 |
| Dec 31, 2024 | 1,298.00 |
| Sep 30, 2024 | 2,083.00 |
| Jun 30, 2024 | 4,648.00 |
| Mar 31, 2024 | 6,603.00 |
| Dec 31, 2023 | 4,979.00 |
| Sep 30, 2023 | 4,353.00 |
| Jun 30, 2023 | -2,707.00 |
| Mar 31, 2023 | 2,176.00 |
| Dec 31, 2022 | 689.00 |
| Sep 30, 2022 | -448.00 |
| Jun 30, 2022 | 2,826.00 |
| Mar 31, 2022 | -7,244.00 |
| Dec 31, 2021 | -3,275.00 |
| Sep 30, 2021 | -2,007.00 |